膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016218)
◆英語タイトル:Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016218
◆発行日:2019年01月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018]についてメールでお問い合わせはこちら
※本調査レポートでは、世界における膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬開発に取り組んでいる企業情報も提供しています。

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の概要

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の治療薬パイプライン概要

・企業別開発中の膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Exocrine Pancreatic Insufficiency. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Exocrine Pancreatic Insufficiency. DelveInsight’s Report also assesses the Exocrine Pancreatic Insufficiency therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Exocrine Pancreatic Insufficiency
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Exocrine Pancreatic Insufficiency pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Exocrine Pancreatic Insufficiency and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Exocrine Pancreatic Insufficiency Overview
• Exocrine Pancreatic Insufficiency Pipeline Therapeutics
• Exocrine Pancreatic Insufficiency Therapeutics under Development by Companies
• Exocrine Pancreatic Insufficiency Filed and Phase III Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Phase II Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Phase I and IND Filed Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Exocrine Pancreatic Insufficiency – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency – Discontinued Products
• Exocrine Pancreatic Insufficiency – Dormant Products
• Companies Involved in Therapeutics Development for Exocrine Pancreatic Insufficiency
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Exocrine Pancreatic Insufficiency, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Exocrine Pancreatic Insufficiency Assessment by Monotherapy Products
• Exocrine Pancreatic Insufficiency Assessment by Combination Products
• Exocrine Pancreatic Insufficiency Assessment by Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Stage and Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency Assessment by Stage and Molecule Type
• Exocrine Pancreatic Insufficiency Therapeutics – Discontinued Products
• Exocrine Pancreatic Insufficiency Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Exocrine Pancreatic Insufficiency, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Exocrine Pancreatic Insufficiency Assessment by Monotherapy Products
• Exocrine Pancreatic Insufficiency Assessment by Combination Products
• Exocrine Pancreatic Insufficiency Assessment by Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Stage and Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency Assessment by Stage and Molecule Type


*** レポートのキーワード ***

膵外分泌機能不全(Exocrine Pancreatic Insufficiency)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のトピラマート市場2015
    The 'Global and Chinese Topiramate Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Topiramate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Topiramate manufacturers and i …
  • 世界及び中国の亜セレン酸市場2017
    The 'Global and Chinese Selenous Acid Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Selenous Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Selenous Acid manufactur …
  • クラウドコンピューティングスタックレイヤーの世界市場2016
    The Global Cloud Computing Stack Layers Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cloud Computing Stack Layers industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and …
  • 世界及び中国の酸素流量計市場2016
    The 'Global and Chinese Oxygen flow meter Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Oxygen flow meter industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oxygen flow mete …
  • デジタルボイスレコーダーの世界市場2015
    Global Digital Voice Recorder Industry Report 2015 is a professional and in-depth study on the current state of the Digital Voice Recorder industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Digital Voi …
  • 商業用建設市場動向:タイ-市場予測
    This report is the result of Timetric’s extensive market research covering the commercial construction industry in Thailand. It contains detailed historic and forecast market value data for the commercial construction industry, including a breakdown of the data by construction activity (new construc …
  • カミソリ及びカミソリ用刃市場(~2019):ヨルダン
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for razors and razor blades in Jordan. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industr …
  • パン改良剤の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)
    Bread improver is a blend of ingredients that activate the gluten and help produce gas which assists and improves the processes of dough kneading and fermentation. The result is a lighter loaf with better texture and keeping qualities. They are used more often in grain mixes or breads with addition …
  • アジア太平洋における産業自動化制御市場(2014-2018)
    About Industrial Automation An industrial automation control system helps organizations, especially those in process and discrete industries, optimize their business operations by effectively controlling the production process. Industrial automation systems include five major types: DCS, PLC, MES, A …
  • CH2M Hill Companies, Ltd.(代替エネルギー分野):企業のM&A・提携動向
    Summary CH2M HILL Companies, Ltd. (CH2M HILL) is a heavy construction contractor, offering engineering, design, construction, project management and related technical services. The company also provides startup and performance testing, consulting, asset management, facility operations, and on-going …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016218 )"膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018" (英文:Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。